Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stumptner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 14, 2000
Identification of p62, a phosphotyrosine independent ligand of p56lck kinase, as a major component of intracytoplasmic hyaline bodies in hepatocellular carcinomaC Stumptner, H Heid, K Zatloukal, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 24, 2007
How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseasesA Aigelsreiter, E Janig, C Stumptner, et al.
The American Journal of Pathology|June 11, 1999
Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituentC Stumptner, H Heid, A Fuchsbichler, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 1999
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver diseaseK H Preisegger, V M Factor, A Fuchsbichler, et al.
The American Journal of Pathology|April 7, 2000
Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodiesK Zatloukal, C Stumptner, M Lehner, et al.
The Journal of Pathology|February 16, 2006
Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?H Denk, C Stumptner, A Fuchsbichler, et al.
Hepatology (Baltimore, Md.)|July 1, 1996
Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their productsK H Preisegger, C Stumptner, D Riegelnegg, et al.
Gastroenterology|July 5, 2001
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liverP Fickert, G Zollner, A Fuchsbichler, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseasesG Zollner, P Fickert, R Zenz, et al.
Translational Oncology|February 22, 2020
Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268]N Golob-Schwarzl, K Bettermann, A K Mehta, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 14, 2000
Identification of p62, a phosphotyrosine independent ligand of p56lck kinase, as a major component of intracytoplasmic hyaline bodies in hepatocellular carcinomaC Stumptner, H Heid, K Zatloukal, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 24, 2007
How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseasesA Aigelsreiter, E Janig, C Stumptner, et al.
The American Journal of Pathology|June 11, 1999
Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituentC Stumptner, H Heid, A Fuchsbichler, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 1999
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver diseaseK H Preisegger, V M Factor, A Fuchsbichler, et al.
The American Journal of Pathology|April 7, 2000
Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodiesK Zatloukal, C Stumptner, M Lehner, et al.
The Journal of Pathology|February 16, 2006
Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?H Denk, C Stumptner, A Fuchsbichler, et al.
Hepatology (Baltimore, Md.)|July 1, 1996
Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their productsK H Preisegger, C Stumptner, D Riegelnegg, et al.
Gastroenterology|July 5, 2001
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liverP Fickert, G Zollner, A Fuchsbichler, et al.
Hepatology (Baltimore, Md.)|March 7, 2001
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseasesG Zollner, P Fickert, R Zenz, et al.
Translational Oncology|February 22, 2020
Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268]N Golob-Schwarzl, K Bettermann, A K Mehta, et al.
Pageof 2